Track record

Pediatrix Medical Group, Inc. (MD) stock forecast — our track record

1 completed MD stock prediction — wins and misses, nothing deleted. Each forecast was published before the outcome was known.

1
completed prediction — every MD call whose window has closed
1 of 1
hit or exceeded the predicted growth
+27.4%
median peak gain inside the window — peak, not a realized return
Every call, month by monthOne cell per closed signal
1 Target reached
0 Partial
0 Missed

How our MD forecasts have done

Lyra published 1 MD stock forecast, with the first prediction dated November 3, 2025. It used a short term (0 to 3 months) horizon. The forecast window ended on February 1, 2026. The signal was published before the outcome was known, then closed and scored after the window finished. This track record covers that completed call only.

The prediction reached its target. There were no misses. The average success score was 100%. The short term average score was also 100%, matching the overall result because every forecast used the same horizon. The stock rose as much as 27.4% during the scoring window, and the target was reached in 17 days.

The best call was the November 3, 2025 short term forecast, which looked for 20% growth. The stock rose as much as 27.4%, reached the target in 17 days, and received a 100% score. The worst call was the same November 3, 2025 forecast, because there was only one completed signal. It also looked for 20% growth, rose as much as 27.4%, reached the target in 17 days, and received a 100% score. The record was perfect, but it was based on a single completed forecast.

Written from the closed signals below; refreshed when new signals close.

Closed MD signals

ClosedTimeframePredictedPeak resultOutcomeDays to target
February 1, 2026

Peak result is the highest point inside the signal’s measurement window — labelled as peak because it is not a realized return.

Share this receipt

The full public record for this symbol — wins and misses. Paste the link anywhere — it unfurls as the card above.

Lyra

See what we’re calling today.

Every published signal is scored against what the stock actually did — the same way MD was. No deleted misses, no cherry-picking.